Companies / Vera Therapeutics, Inc. / Activity
Activity — Vera Therapeutics, Inc.
30 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Fordyce Marshall CEO | Sell | Class A Common Stock | $710.6K | -17K -6.17% | 257,163 0.36% of shares | medium |
| Feb 23, 2026 | Grant Sean Executive | Sell | Class A Common Stock | $207.8K | -5K -4.15% | 114,181 0.16% of shares | medium |
| Feb 23, 2026 | Young Joseph R Executive | Sell | Class A Common Stock | $130.9K | -3K -4.59% | 64,722 0.09% of shares | medium |
| Feb 23, 2026 | Johnson David Lee Executive | Sell | Class A Common Stock | $108.3K | -3K -5.34% | 45,727 0.06% of shares | medium |
| Feb 23, 2026 | Turner William D. Executive | Sell | Class A Common Stock | $91.8K | -2K -4.60% | 45,313 0.06% of shares | low |
| Feb 23, 2026 | Brenner Robert Executive | Sell | Class A Common Stock | $90.3K | -2K -4.05% | 50,947 0.07% of shares | low |
| Feb 23, 2026 | Skelton Laurence Matthew Executive | Sell | Class A Common Stock | $66.4K | -2K -2.40% | 64,218 0.09% of shares | low |
| Mar 13, 2026 | Young Joseph R Executive | Exercise | Class A Common Stock | $39.4K | +10K +15.21% | 75,754 0.11% of shares | low |
| Mar 23, 2026 | Wright-Mitchell Jane Executive | Grant | Class A Common Stock | $0 | +42K | 42,403 0.06% of shares | low |
| Feb 4, 2026 | Skelton Laurence Matthew Executive | Grant | Class A Common Stock | $0 | +20K +43.67% | 65,800 0.09% of shares | low |
| Feb 4, 2026 | Brenner Robert Executive | Grant | Class A Common Stock | $0 | +25K +88.97% | 53,098 0.07% of shares | low |
| Feb 4, 2026 | Grant Sean Executive | Grant | Class A Common Stock | $0 | +25K +26.56% | 119,130 0.17% of shares | low |
| Feb 4, 2026 | Young Joseph R Executive | Grant | Class A Common Stock | $0 | +10K +17.29% | 67,839 0.09% of shares | low |
| Feb 4, 2026 | Fordyce Marshall CEO | Grant | Class A Common Stock | $0 | +69K +33.51% | 274,088 0.38% of shares | low |
| Feb 4, 2026 | Turner William D. Executive | Grant | Class A Common Stock | $0 | +25K +111.11% | 47,500 0.07% of shares | low |
| Feb 4, 2026 | Johnson David Lee Executive | Grant | Class A Common Stock | $0 | +20K +70.66% | 48,306 0.07% of shares | low |
| May 21, 2026 | Meyers James R Director | Grant | Stock Option (right to buy) | — | +17K | 17,084 0.02% of shares | low |
| May 21, 2026 | Enright Patrick G Director | Grant | Stock Option (right to buy) | — | +17K | 17,084 0.02% of shares | low |
| May 21, 2026 | Morrissey Michael Director | Grant | Stock Option (right to buy) | — | +17K | 17,084 0.02% of shares | low |
| May 21, 2026 | Seidenberg Beth C Director | Grant | Stock Option (right to buy) | — | +17K | 17,084 0.02% of shares | low |
| Mar 23, 2026 | Wright-Mitchell Jane Executive | Grant | Stock Option (right to buy) | — | +57K | 56,850 0.08% of shares | low |
| Mar 13, 2026 | Young Joseph R Executive | Exercise | Stock Option (right to buy) | — | -10K -20.58% | 38,589 0.05% of shares | low |
| Mar 5, 2026 | Hite Christopher Director | Grant | Stock Option (right to buy) | — | +25K | 24,937 0.03% of shares | low |
| Feb 4, 2026 | Skelton Laurence Matthew Executive | Grant | Stock Option (right to buy) | — | +40K | 40,000 0.06% of shares | low |
| Feb 4, 2026 | Brenner Robert Executive | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.07% of shares | low |
| Feb 4, 2026 | Grant Sean Executive | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.07% of shares | low |
| Feb 4, 2026 | Young Joseph R Executive | Grant | Stock Option (right to buy) | — | +20K | 20,000 0.03% of shares | low |
| Feb 4, 2026 | Fordyce Marshall CEO | Grant | Stock Option (right to buy) | — | +138K | 137,500 0.19% of shares | low |
| Feb 4, 2026 | Turner William D. Executive | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.07% of shares | low |
| Feb 4, 2026 | Johnson David Lee Executive | Grant | Stock Option (right to buy) | — | +40K | 40,000 0.06% of shares | low |